AKAkira Kawashima

Akira Kawashima

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Akira Kawashima has a total of 273 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Utility of PSA density velocity in diagnosing prostate cancer on prostate MR

    by Sabarish Narayanasamy, Yasuhisa Kurata, Ayumu Kido, Hirotsugu Nakai, Hiroaki Takahashi, Jordan D LeGout, Adam T Froemming, Akira Kawashima, Abhinav Khanna, Naoki Takahashi

  • Cryoablation for Prostate Cancer

    by David A. Woodrum, Akira Kawashima, Krzysztof R. Gorny, Lance A. Mynderse

  • Deep learning–based prostate cancer diagnosis on MRI with hip prostheses: artifact and sequence effects

    by Hirotsugu Nakai, Yasuhisa Kurata, Hiroaki Takahashi, Daniel Adamo, Adam Froemming, Jordan LeGout, Akira Kawashima, Jason Cai, Ayumu Kido, Shiba Kuanar, et al.

  • Imaging of Complications after Prostate Interventions.

    by Cole P Thompson, Hiroaki Takahashi, Stephen M Broski, Adam T Froemming, Naoki Takahashi, David A Woodrum, Jack R Andrews, Akira Kawashima

    Prostate interventions are increasingly employed in management of benign prostatic hyperplasia (BPH) and prostate cancer. Routinely performed procedures include a widening array of surgical therapies for BPH, prostate needle biopsy, focal therapies, radical prostatectomy, and radiation therapy. While generally safe, these interventions are associated with various complications, broadly categorized as vascular, infectious, urinary, radiation related, and miscellaneous. CT is the first-line modality for detection of early complications, such as active hemorrhage and postoperative fluid collections. Fluoroscopic studies such as voiding cystourethrography and conventional cystography assist in evaluation of urinary leaks, fistulas, and strictures. MRI is particularly useful for characterization of late complications, such as complex urinary fistulas and pubic osteomyelitis, as well as detection of local recurrence alongside prostate-specific membrane antigen (PSMA) PET/CT or PET/MRI. Familiarity with expected and unexpected postinterventional imaging findings is essential to avoid delayed diagnosis and guide appropriate management. The authors highlight key complications through illustrative cases across multiple imaging modalities. ©RSNA, 2026 Supplemental material is available for this article.

  • Rosai-Dorfman Disease: Imaging and Updates

    by Amar S. Shah, Mohd Javed Saifullah Shaikh, Nishant Aswani, Leonardo Gomes Marcelino, Zubin Vicky Driver, Galib Mirza Nasirul Islam, Sedat Kandemirli, Akira Kawashima, Carol J. Homan, Eli Diamond, et al.

    Although Rosai-Dorfman disease has nonspecific imaging features, imaging remains essential for delineating disease extent, predicting prognosis, and assessing treatment response once the diagnosis is established through integrated clinical, imaging, and histopathologic evaluation.


  • Open Access

    Optimal Selection of the Effective Echo Time ( TE eff ) for T2 ‐Weighted Fast‐Spin‐Echo MRI of the Prostate at 3.0 T: Effect on Lesion Conspicuity

    by Dahan Kim, Ronard Pabi, Eric A. Borisch, Adam T. Froemming, Roger C. Grimm, Sara Hassanzadeh, Akira Kawashima, Ayumu Kido, Naoki Takahashi, John V. Thomas, et al.

    Background: Clinical T 2 ‐weighted (T2W) MRI of prostate cancer (PCa) usually implements a 2D fast‐spin‐echo (FSE) sequence, but understanding the echo‐time‐dependent contrast behavior is not straightforward due to the complicated FSE signal evolution. Consequently, consensus‐based recommendations on the optimal effective echo time (TE eff ) to maximize contrast are lacking. Purpose: To investigate the effect of TE eff on PCa lesion contrast in prostate T2W MRI. Study Type: Phantom and in vivo prospective study. Subjects: A standard MRI phantom and 53 prostate cancer patients (29 for image evaluation and 24 for quantitative lesion analysis). Field Strength and Sequence: Multi‐slice T2W FSE sequence at 3 T acquired at multiple TE eff values. Assessment: Three readers (13, 25, and 27 years' experience) evaluated TE eff = 100 ms versus 150 ms on diagnostic quality and reader preference. The effective T 2 relaxation rates ( T 2,eff ) were measured using FSE sequences in the phantom and used to predict the optimal TE eff maximizing T2W contrasts. From multi‐TE eff scans of subjects with suspected PCa, T 2,eff values of PCa lesions and healthy tissue were measured and used to calculate the optimal TE eff maximizing the lesion contrast. In vivo contrast metrics were measured as a function of TE eff . Statistical Tests: Wilcoxon test of reader scores, with p < 0.05 defining statistical significance. Results: No statistically significant difference was found in diagnostic quality between TE eff = 150 ms and 100 ms images, but all three readers significantly favored TE eff = 150 ms. Phantom experiments demonstrated that TE eff ‐dependent FSE signal progression can be characterized by T 2,eff values typically 40% longer than actual T 2 values, allowing accurate prediction of optimal TE eff within 2%–5%. Applied to PCa imaging, in vivo measurements indicated that effective T 2 relaxation times of the prostate are on average 1.5× longer than published T 2 values. Data Conclusion: The benefits of TE eff = 150 ms versus 100 ms in prostate T2W FSE were supported by reader preference, phantom experiments, in vivo measurements, and analytic optimizations. Evidence Level: 2. Technical Efficacy: 2.

  • Scrotal uptake on PSMA PET in prostate cancer: differentiating metastases from benign and physiologic findings using ultrasound correlation

    by Hiroaki Takahashi, Theodra A. Potretzke, Eric C. Ehman, Derek J. Lomas, Lauren F. Alexander, Eugene D. Kwon, Akira Kawashima

    Purpose To identify imaging and clinical features that aid in distinguishing metastatic lesions from benign or physiologic uptake on PSMA PET, using correlation with scrotal ultrasound. Methods This IRB-approved retrospective study included prostate cancer (PCa) patients who underwent PSMA PET-CT or PET-MRI between July 2021 and May 2025, with a scrotal ultrasound performed within 100 days of the scan. PSMA-avid lesions were assessed for uptake intensity (mild vs. intense), distribution (diffuse vs. focal), laterality (unilateral vs. bilateral), scan indication (initial staging vs. restaging), and SUVmax. Ultrasound findings were reviewed, and metastasis was confirmed by pathology or clinical consensus by three board-certified radiologists. Multivariable logistic regression using LASSO was performed to identify predictors of testicular or paratesticular metastasis. Results Of 114 patients (mean age 70), 24 (21%) demonstrated scrotal PSMA uptake. Focal intense uptake was seen in 6 patients (all unilateral), and mild focal uptake in 17 (13 bilateral, 4 unilateral). One patient showed mild diffuse bilateral uptake; no cases had intense diffuse uptake. Metastasis was confirmed in 5 patients, all of whom showed focal, unilateral, intense uptake. Among the 17 with mild focal uptake, 16 (94%) had no ultrasound abnormalities, consistent with physiologic epididymal uptake. Of 12 patients with ultrasound findings of epididymitis or orchitis, only 2 showed PSMA uptake (1 intense, 1 mild), while 10 had none. LASSO regression identified uptake intensity, SUVmax, PET indication, and laterality as significant predictors of metastasis. PET indication showed the strongest association with metastasis (coefficient = 4.60), followed by uptake intensity (3.97), SUVmax (1.37), and laterality (0.37), indicating a higher likelihood of metastasis in unilateral, intensely avid lesions, particularly in restaging settings. Conclusion Focal, unilateral, intense PSMA uptake, especially during restaging, was strongly associated with testicular or paratesticular metastasis. In contrast, mild or bilateral uptake without ultrasound abnormalities was typically physiologic. Combined assessment using PSMA PET and scrotal ultrasound improves diagnostic accuracy in evaluating scrotal findings in PCa patients.


  • Multisystemic Imaging Features of Coccidioidomycosis

    by Logan P. Haug, Harrison Lang, Muhammad Naeem, Akira Kawashima, Clinton Jokerst, Ichiro Ikuta, Jeremiah R. Long, Mark Sugi, Motoyo Yano, Nelly Tan, et al.

    An understanding of regions of endemicity and the spectrum of organ system involvement can improve recognition of the imaging features of coccidioidomycosis, which can overlap with those of other diseases.


  • Imaging Hereditary Cancer Syndromes in the Abdomen and Pelvis

    by Garima Suman, Avinash Nehra, Kim Bohyun, Mark Nathan, Jay Heiken, Akira Kawashima

    Radiologists are uniquely positioned to play a critical role in the detection, surveillance, and characterization of hereditary abdominal cancer syndromes.

  • Bias in deep learning-based image quality assessments of T2-weighted imaging in prostate MRI

    by Hirotsugu Nakai, Adam T. Froemming, Akira Kawashima, Jordan D. LeGout, Yasuhisa Kurata, Jacob N. Gloe, Eric A. Borisch, Stephen J. Riederer, Naoki Takahashi

    Objectives To determine whether deep learning (DL)-based image quality (IQ) assessment of T2-weighted images (T2WI) could be biased by the presence of clinically significant prostate cancer (csPCa). Methods In this three-center retrospective study, five abdominal radiologists categorized IQ of 2,105 transverse T2WI series into optimal, mild, moderate, and severe degradation. An IQ classification model was developed using 1,719 series (development set). The agreement between the model and radiologists was assessed using the remaining 386 series with a quadratic weighted kappa. The model was applied to 11,723 examinations that were not included in the development set and without documented prostate cancer at the time of MRI (patient age, 65.5 ± 8.3 years [mean ± standard deviation]). Examinations categorized as mild to severe degradation were used as target groups, whereas those as optimal were used to construct matched control groups. Case-control matching was performed to mitigate the effects of pre-MRI confounding factors, such as age and prostate-specific antigen value. The proportion of patients with csPCa was compared between the target and matched control groups using the chi-squared test. Results The agreement between the model and radiologists was moderate with a quadratic weighted kappa of 0.53. The mild-moderate IQ-degraded groups had significantly higher csPCa proportions than the matched control groups with optimal IQ: moderate (N = 126) vs. optimal (N = 504), 26.3% vs. 22.7%, respectively, difference = 3.6% [95% confidence interval: 0.4%, 6.8%], p = 0.03; mild (N = 1,399) vs. optimal (N = 1,399), 22.9% vs. 20.2%, respectively, difference = 2.7% [0.7%, 4.7%], p = 0.008. Conclusion The DL-based IQ tended to be worse in patients with csPCa, raising concerns about its clinical application. Graphical abstract